Durable Remission of Highly Refractory Multiple Myeloma and Therapy-Related MDS/AML After Allogeneic Hematopoietic Cell Transplantation: Reconsidering Its Role in the CAR-T Era.

Saved in:
Bibliographic Details
Title: Durable Remission of Highly Refractory Multiple Myeloma and Therapy-Related MDS/AML After Allogeneic Hematopoietic Cell Transplantation: Reconsidering Its Role in the CAR-T Era.
Authors: Kumamoto T; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan., Yoshihara K; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan.; Department of Transfusion Medicine and Cellular Therapy Hyogo Medical University Hospital Nishinomiya Japan., Samori M; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan., Takahashi S; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan., Yamagata F; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan., Fujita Y; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan., Utsunomiya N; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan., Yoshihara S; Department of Hematology Hyogo Medical University School of Medicine Nishinomiya Japan.; Department of Transfusion Medicine and Cellular Therapy Hyogo Medical University Hospital Nishinomiya Japan.
Source: EJHaem [EJHaem] 2026 Apr 10; Vol. 7, pp. e70282. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2688-6146
DOI:10.1002/jha2.70282